Test Selection and Interpretation Guide
Test Selection and Interpretation Guide 2012
This useful guide provides testing information in 9 clinical specialties: cardiology, chronic kidney disease, coagulation, endocrinology, genetics, hematology/oncology, immunology, infectious diseases, and toxicology. The information provided is based on peer-reviewed publications.
Visit Our New Upcoming Events Center For Event Details
Is your patient at increased risk for hereditary breast and ovarian cancer?
Compared to the general population, a woman with a confirmed BRCA1 or BRCA2 mutation is at greater risk of developing cancer during her lifetime—up to an 85% risk of breast cancer and up to a 40% risk of ovarian cancer. Her children, siblings and parents have a 50% chance of having the same autosomal dominant mutation and facing comparable risks. Learn more.
Putting Vitamin D to the Test: The QuestAssureD™ Difference
To learn more about the differences in vitamin D testing methodologies and why methodology matters, watch this brief two minute video.
Abstract awarded a Best Poster designation by the American College of Cardiology at ACC.14
Testing a panel of 12 single-nucleotide polymorphims (SNPs) may help identify people at increased risk of atrial fibrillation and stroke, according to a recent study by researchers from the Lund University in Malmö, Sweden, the Broad Institute, Harvard Medical School, Cambridge, MA, and Quest Diagnostics. Individuals with the highest genetic risk scores based on the SNP panel had twice the risk of atrial fibrillation compared with those with the lowest scores, as well as a 23% greater risk of stroke. The preliminary results were presented in an award-winning poster at the 2014 Annual Scientific Session & Expo of the American College of Cardiology. ACC attendees may access poster #122 at the ACC.14 Attendee Portal.
Dr. Dale Schwab helps the viewer to understand the Vaginal Microbiome Diversity and the complexities of diagnosing vaginitis and cervicitis as well as discuss how to diagnose occult CT/GC infections in women with vaginitis. ASCLS P.A.C.E.® credits available to laboratory professionals through January 16, 2015.
Quest Diagnostics’ Frederic Waldman, MD, and Wendy Conlon, CGC, will present an in-depth look at BRCA1 and BRCA2 testing, describe the role of the genetic counselor in the management of patients and explain the details of the Quest Diagnostics BRCAvantage™ tests and how to interpret results.
While recommendations for dietary intake of omega-3 fatty acids to reduce cardiovascular disease risk are well established, debate continues about the benefits of...
Many types of epilepsy are associated with a genetic mutation, but determining the etiology of certain epilepsies remains a challenge. Dr. Scott...
Compared to the general population, patients with a confirmed BRCA mutation have a significantly increased risk of developing cancer during their lifetime -...
Causes of developmental delay are typically identified by a combination of observation, physical examination, assessment of family history and a range of diagnostic...
The National Institutes of Health are in the process of establishing a standardized approach for vitamin D Testing. This promises to improve the...
The Centers for Disease Control and Prevention (CDC) has proposed a new algorithm for laboratory testing of human immunodeficiency virus (HIV) to replace...